The two tech giants have now cleared a key hurdle to completing their merger, company officials revealed recently. 

Pylarify is a F 18-labeled, prostate-specific membrane antigen targeted PET agent used to pinpoint suspected metastasis or recurrence of the disease. 

Most nonhospital-based groups fall outside of the new CMS rule, but there’s still an opportunity to adopt this mindset and attract new customers, experts wrote recently. 

Rad involvement in these value-minded care-coordination efforts leapt threefold, preparing members of the specialty to take on downside risk while strengthening bonds with hospital partners.

The final rule would eliminate lag time between the FDA approving new technology and the Centers for Medicare & Medicaid Services paying for it. 

Representatives recently introduced the Improving Seniors’ Timely Access to Care Act in the U.S. House, drawing support from the ACR, Medical Group Management Association and others. 

The college is concerned gray areas in the No Surprises Act give health insurers leeway “that could be used as leverage to disrupt good-faith negotiations.” 

The Indiana Court of Appeals recently sided with Lake Imaging, agreeing that the Medical Malpractice Act and its statute of limitations also apply to provider relationships.